Tu1743 CHARACTERIZING DISTINCT FIBROBLAST SUBPOPULTIONS IN INFLAMMATORY AND FIBROSTENOTIC CROHN'S DISEASE USING SINGLE CELL RNA SEQUENCING S Sun, S de Jong, N Sinnema, R Oelen, J Teunis, G Kats-Ugurlu, ... Gastroenterology 166 (5), S-1402, 2024 | | 2024 |
Tu1193 THERAPEUTIC POTENTIAL OF PIRFENIDONE IN IL13RA2-EXPRESSING PRIMARY HUMAN INFLAMMATION-ASSOCIATED FIBROBLASTS L Wang, S de Jong, N Sinnema, J Teunis, RK Weersma, E Bigaeva, ... Gastroenterology 166 (5), S-1276, 2024 | | 2024 |
Mo1794 CROHN'S DISEASE-ASSOCIATED PATHOGENIC MUTATION IN MANGANESE TRANSPORTER ZIP8 SHIFTS THE ILEAL AND RECTAL MUCOSAL MICROBIOTA IMPLICATING ABERRANT BILE ACID METABOLISM K Briggs, V Tomar, N Ollberding, Y Haberman, AR Bourgonje, S Hu, ... Gastroenterology 166 (5), S-1114, 2024 | | 2024 |
Sa1787 SYSTEMIC REDOX STATUS ASSOCIATES WITH DISEASE ACTIVITY AND CLINICAL PHENOTYPES IN INFLAMMATORY BOWEL DISEASE S Geertsema, AR Bourgonje, R Gacesa, RR Fagundes, LM Spekhorst, ... Gastroenterology 166 (5), S-522-S-523, 2024 | | 2024 |
Sa1189 DECODING DONOR AND RECIPIENT CELL DYNAMICS IN THE SMALL INTESTINAL GRAFT WITHIN SIX MONTHS POST-TRANSPLANTATION N Karmi, R Oelen, E Bigaeva, S de Jong, JW Haveman, F van der Heide, ... Gastroenterology 166 (5), S-378-S-379, 2024 | | 2024 |
394 YIELD OF SURVEILLANCE COLONOSCOPY IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS N van de Pol, B Mol, MJ de Jong, RK Weersma, A Inderson, FC Slooter, ... Gastroenterology 166 (5), S-89-S-90, 2024 | | 2024 |
34 SINGLE-CELL RNA SEQUENCING IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE: A DISTINCT FORM OF COLITIS A Bangma, P Pibiri, S Sun, E Bigaeva, S de Jong, JR Björk, ... Gastroenterology 166 (5), S-13, 2024 | | 2024 |
117 CHANGES IN SYSTEMIC ANTIBODY EPITOPE REPERTOIRES FROM PRECLINICAL TO ESTABLISHED INFLAMMATORY BOWEL DISEASE AR Bourgonje, S Andreu-Sánchez, R Gacesa, S Klompus, IN Kalka, ... Gastroenterology 166 (5), S-33, 2024 | | 2024 |
The gut microbiome in end-stage lung disease and lung transplantation S Zhang, JC Swarte, R Gacesa, TJ Knobbe, D Kremer, BH Jansen, ... Msystems, e01312-23, 2024 | | 2024 |
Exploring the Predictive Value of Gut Microbiome Signatures for Therapy Intensification in Patients With Inflammatory Bowel Disease: A 10-Year Follow-up Study ZMA Al Radi, FM Prins, V Collij, A Vich Vila, EAM Festen, G Dijkstra, ... Inflammatory Bowel Diseases, izae064, 2024 | | 2024 |
Genome-Wide Studies Reveal Genetic Risk Factors for Hepatic Fat Content Y Li, EH van den Berg, A Kurilshikov, DV Zhernakova, R Gacesa, S Hu, ... Genomics, Proteomics & Bioinformatics, qzae031, 2024 | | 2024 |
Gut microbial metabolism of 5-aminosalicylic acid in inflammatory bowel disease N Karmi, S Sun, EAM Festen, AV Vila, R Gacesa, RK Weersma Gut, 2024 | | 2024 |
Iron deficiency, anemia, and patient-reported outcomes in kidney transplant recipients D Kremer, TJ Knobbe, JSJ Vinke, D Groothof, A Post, C Annema, ... American Journal of Transplantation, 2024 | | 2024 |
Human leukocyte antigen signatures as pathophysiological discriminants of microscopic colitis subtypes T Zheng, G Roda, Y Zabana, C Escudero-Hernández, X Liu, Y Chen, ... Journal of Crohn's and Colitis 18 (3), 349-359, 2024 | 2 | 2024 |
Longitudinal analysis shows how microbiome changes might influence responses to immune checkpoint blockade JR Bjork, GAP Hospers, RK Weersma NATURE MEDICINE, 2024 | | 2024 |
Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease S Hu, AR Bourgonje, R Gacesa, BH Jansen, JR Björk, A Bangma, ... Nature Communications 15 (1), 1470, 2024 | 2 | 2024 |
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma JR Björk, LA Bolte, A Maltez Thomas, KA Lee, N Rossi, TT Wind, LM Smit, ... Nature Medicine, 1-12, 2024 | 5 | 2024 |
Choice of DNA extraction method affects stool microbiome recovery and subsequent phenotypic association analyses A Fernández-Pato, T Sinha, R Gacesa, S Andreu-Sánchez, MFB Gois, ... Scientific Reports 14 (1), 3911, 2024 | | 2024 |
Crohn’s Disease–Associated Pathogenic Mutation in the Manganese Transporter ZIP8 Shifts the Ileal and Rectal Mucosal Microbiota Implicating Aberrant Bile Acid Metabolism K Briggs, V Tomar, N Ollberding, Y Haberman, AR Bourgonje, S Hu, ... Inflammatory Bowel Diseases, izae003, 2024 | | 2024 |
Melanoma and microbiota: Current understanding and future directions B Routy, T Jackson, L Mählmann, CK Baumgartner, M Blaser, A Byrd, ... Cancer Cell, 2024 | 3 | 2024 |